Peripheral T-cell Lymphomas (PTCL): Clinical Trials

1 trial for Peripheral T-cell Lymphomas (PTCL), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Peripheral T-cell Lymphomas (PTCL): new trials by email Literature Review of Peripheral T-cell Lymphomas (PTCL) trials Research Report on Peripheral T-cell Lymphomas (PTCL)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas
Ro-CHOEP-21 (PHASE I), Ro-CHOEP-21 (PHASE II) - Peripheral T-cell Lymphomas (PTCL), PTCL-NOS
Phase 1 / Phase 2CompletedFondazione Italiana Linfomi - ETS892014-09-012026-08-19

Narrower conditions

Immunoblastic Lymphadenopathy (1)  ·  Lymphoma, T-Cell, Peripheral (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphadenopathy (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Clinical Trials, Phase I as Topic (1)  ·  Clinical Trials, Phase II as Topic (1)  ·  Cyclophosphamide (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Prednisone (1)  ·  Vincristine (1)  ·  romidepsin (1)

Sponsors

Fondazione Italiana Linfomi - ETS (1)

Countries

Italy (1)

Top investigators

Paolo Corradini, Prof (1)